Calendar FSD Pharma Inc.

Equities

Delayed Canadian Securities Exchange Other stock markets 14:07:56 2024-04-30 EDT			5-day change	1st Jan Change
0.57 ^CAD	-1.72%		-10.94%	-52.50%

02:33pm	FSD Pharma Inc. Signs Agreement with Applied Science and Performance Institute to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of Unbuzzd? in an Induced State of Alcohol Intoxication	CI
04-25	FSD Pharma Says Celly Nutrition Partners with Six+One for US Launch of Dietary Supplement	MT

9d.4YyBVE9XIpVjThEEdgTdktlHmju7z-pw7U0GoJAMZOg.r-2xbDgySe0BKFxTT0OS550E22TooaIAhxdMkeVACa2CzvQSIGMTwhAvKQ~002973754a5db00b3757175c471a4ff9

2024-05-09	Q1 2024 Earnings Release (Projected)
2024-08-08	Q2 2024 Earnings Release (Projected)
2024-11-12	Q3 2024 Earnings Release (Projected)
2025-03-26	Q4 2024 Earnings Release (Projected)

2024-03-28 16:54	Q4 2023 Earnings Release
2023-11-20 13:00	Extraordinary Shareholders Meeting
2023-11-14 16:13	Q3 2023 Earnings Release
2023-10-10	ECTRIMS-ACTRIMS Meeting
2023-06-29 13:00	Annual General Meeting
2023-05-17	Q1 2023 Earnings Release (Projected)
2023-05-11 15:15	Sidoti Micro-Cap Virtual Conference
2023-03-31 17:53	Q4 2022 Earnings Release
2023-02-24 21:30	Americas Committee for Treatment and Research inMultiple Sclerosis Forum - Safety and Toxicokinetic
2023-02-24 21:30	Americas Committee for Treatment and Research inMultiple Sclerosis Forum - Treatment with Lucid-21-3
2023-01-08	JP Morgan Healthcare Conference
2022-11-11 17:06	Q3 2022 Earnings Release
2022-09-12 07:00	H.C. Wainwright Global Investment Conference
2022-08-12 16:24	Interim 2022 Earnings Release
2022-06-23 13:00	Annual General Meeting
2022-05-13 16:32	Q1 2022 Earnings Release
2022-03-31 09:18	FY 2021 Earnings Release
2022-01-10 07:00	H.C. Wainwright BioConnect Conference
2021-12-06 07:00	H.C. Wainwright Psychedelics Conference
2021-11-12 17:37	Q3 2021 Earnings Release

Fiscal Period	December	2019	2020
Net sales Million CAD	Released Forecast Spread	0,26 0,32 -20.31%	0,00 0,00 -
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBIT Million CAD	Released Forecast Spread	0,00 0,00 -	-38,2 -48,4 21.03%
Earnings before Tax (EBT)	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
Net income Million CAD	Released Forecast Spread	-52,0 -45,3 -14.93%	-39,6 -54,1 26.78%
EPS CAD	Released Forecast Spread	-7,37 -6,19 -19.06%	0,00 -5,32 -
Announcement Date		03/03/20	16/03/21

Today 16:05	EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 07:00	NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
2024-05-01 16:05	SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-01	ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01	DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
2024-05-01	GERON CORPORATION: Q1 2024 Earnings Release

Today	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
Today	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 07:00	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-28	INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release
2024-04-28	HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-27	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release
2024-04-25	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release